The company's financial stability is strained by a debt-to-equity ratio of 0.95 and a stagnant retained earnings balance of negative $1.1 billion, indicating limited internal capital generation.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 |
|---|
| Total Current Assets | 175.34M | 174.38M | 152.02M | 144.44M | 170.14M | 187.1M | 183.43M | 128.11M | 146.9M | 89.9M | 94.11M | 130.44M | 74.87M | 78.15M | 44M | 39.74M | 41.76M | 32.36M | 42.04M | 73.9M | 102.74M | 51.01M | 99.87M | 115.75M | 67.25M | 125.06M | 91.04M | 40.7M | 20.1M | 26.2M |
| Cash & Short-Term Investments | 80.42M | 82.88M | 80.45M | 65.85M | 102.15M | 129.36M | 133.59M | 85.72M | 117.58M | 60.7M | 71.63M | 107.88M | 51.29M | 57.68M | 26.7M | 25.78M | 30.01M | 19.93M | 22.58M | 56.85M | 93.42M | 45.8M | 95.33M | 110.01M | 64.32M | 123.46M | 90.26M | 40.4M | 6.2M | 11.6M |
| Cash Only | 27.85M | 19.96M | 20.27M | 11.65M | 35.59M | 48.76M | 36.59M | 34.99M | 28.86M | 13.68M | 22.56M | 71.02M | 22.78M | 29.48M | 26.7M | 25.5M | 28.95M | 17.29M | 10.3M | 19.63M | 46.29M | 5.78M | 39.17M | 23.16M | 22.43M | 64.5M | 71.87M | 3.5M | 6.2M | 11.6M |
| Short-Term Investments | 52.58M | 62.92M | 60.19M | 54.2M | 66.57M | 80.6M | 97M | 50.73M | 88.72M | 47.01M | 49.07M | 36.86M | 28.51M | 28.19M | 0 | 287K | 1.06M | 2.64M | 12.28M | 37.23M | 47.13M | 40.02M | 56.16M | 86.84M | 41.88M | 58.96M | 18.39M | 36.9M | 0 | 0 |
| Accounts Receivable | 29.32M | 30.37M | 29.78M | 35.5M | 34.43M | 25.13M | 21.17M | 16.88M | 8.75M | 12.41M | 6.87M | 5.79M | 5.49M | 6.13M | 4.44M | 6.1M | 4.79M | 3.63M | 7.15M | 7.77M | 5.28M | 5.2M | 4.54M | 5.74M | 2.93M | 1.6M | 267K | 0 | 0 | 4.4M |
| Days Sales Outstanding | 50.93 | 53.78 | 60.29 | 82.87 | 77.54 | 70.09 | 84.05 | 82.55 | 52.45 | 104.01 | 67.42 | 61.8 | 54.93 | 56.37 | 44.2 | 67.34 | 75.69 | 73.58 | 158.14 | 256.86 | 54.16 | 77.88 | 119.04 | 216.92 | 125.97 | 128.7 | 52.65 | - | - | 232.75 |
| Inventory | 61.12M | 56.1M | 38.15M | 39.87M | 29M | 26.79M | 23.25M | 19.49M | 13.54M | 14.46M | 12.53M | 10.81M | 14.96M | 13.06M | 10.18M | 6.44M | 5.96M | 7.71M | 11.11M | 7.06M | 1.83M | 0 | -4.53M | -5.74M | -2.88M | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 201.59 | 213.65 | 172.45 | 207.98 | 141.23 | 154.07 | 206.23 | 212.87 | 156.22 | 234.2 | 225.37 | 168.19 | 257.79 | 210.95 | 180.23 | 126.9 | 180.5 | 223.61 | 419.4 | 493.04 | 434.16 | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.47M | 5.03M | 3.64M | 3.22M | 4.56M | 0 | 0 | 0 | 0 | 2.33M | 1.8M | 4.75M | 1.93M | 442K | 2.04M | 605K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 512K | 300K | 13.9M | 10.2M |
| Total Non-Current Assets | 47.57M | 47.48M | 48.9M | 53.31M | 47.95M | 50.4M | 37.98M | 37.43M | 16.56M | 8.35M | 9.37M | 9.03M | 6.9M | 5.23M | 4.92M | 5.63M | 6.41M | 2.13M | 5.3M | 4.31M | 13.07M | 7.66M | 2.21M | 2.71M | 5.7M | 3.2M | 3.12M | 1.1M | 800K | 1.1M |
| Property, Plant & Equipment | 18.7M | 19.33M | 15.54M | 19.35M | 23.48M | 25.18M | 26.99M | 29.02M | 8.13M | 2.12M | 2.98M | 3.55M | 3.78M | 2.19M | 1.7M | 2.03M | 2.39M | 1.22M | 1.84M | 1.32M | 1.63M | 1.24M | 947K | 2.55M | 5.55M | 3.01M | 2.99M | 1M | 700K | 1M |
| Fixed Asset Turnover | 12.69x | 10.66x | 11.60x | 8.08x | 6.90x | 5.20x | 3.41x | 2.57x | 7.49x | 20.56x | 12.46x | 9.64x | 9.65x | 18.12x | 21.61x | 16.26x | 9.67x | 14.78x | 8.95x | 8.35x | 21.87x | 19.73x | 14.69x | 3.79x | 1.53x | 1.51x | 0.62x | 2.40x | 4.14x | 6.90x |
| Goodwill | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 132K | 334K | 536K | 738K | 940K | 1.14M | 1.34M | 1.55M | 1.75M | 1.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.73M | 247K | -150K | -122K | -115K | -89K | -62K | 0 | -189.3M | 0 | 2.33M | 2M | 11M | 6M | 1.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 27.55M | 26.83M | 32.04M | 32.64M | 23.15M | 23.9M | 9.68M | 6.96M | 6.78M | 4.38M | 4.33M | 3.23M | 665K | 378K | 363K | 532K | 756K | -181.19M | 1.12M | 2.98M | 11.45M | 6.42M | 85K | 156K | 152K | 188K | 127K | 100K | 100K | 100K |
| Total Assets | 222.91M | 221.86M | 200.92M | 197.75M | 218.09M | 237.5M | 221.41M | 165.53M | 163.46M | 98.24M | 103.48M | 139.47M | 81.77M | 83.38M | 48.92M | 45.37M | 48.17M | 34.49M | 47.34M | 78.21M | 115.82M | 58.66M | 102.08M | 118.46M | 72.95M | 128.26M | 94.16M | 41.8M | 20.9M | 27.3M |
| Asset Turnover | 0.99x | 0.93x | 0.90x | 0.79x | 0.74x | 0.55x | 0.42x | 0.45x | 0.37x | 0.44x | 0.36x | 0.25x | 0.45x | 0.48x | 0.75x | 0.73x | 0.48x | 0.52x | 0.35x | 0.14x | 0.31x | 0.42x | 0.14x | 0.08x | 0.12x | 0.04x | 0.02x | 0.06x | 0.14x | 0.25x |
| Asset Growth % | 46.62% | 10.42% | 1.6% | -9.33% | -8.17% | 7.26% | 33.76% | 1.27% | 66.38% | -5.06% | -25.81% | 70.56% | -1.93% | 70.45% | 7.83% | -5.81% | 39.65% | -27.14% | -39.47% | -32.47% | 97.44% | -42.53% | -13.83% | 62.4% | -43.13% | 36.21% | 125.27% | 100% | -23.44% | - |
| Total Current Liabilities | 107.38M | 100.8M | 63.61M | 67.52M | 117.06M | 78.56M | 59.97M | 50.34M | 52.68M | 23.13M | 26.89M | 21.89M | 29M | 39.42M | 25.61M | 21.11M | 19.7M | 12.91M | 12.9M | 18.32M | 14.81M | 23.32M | 76.09M | 65.94M | 16.76M | 16.45M | 12.16M | 8.7M | 19.6M | 4.8M |
| Accounts Payable | 0 | 28.01M | 21.7M | 23.84M | 33M | 35.61M | 24.21M | 22.18M | 18.59M | 10.97M | 8.59M | 5.22M | 9.88M | 5.67M | 7.19M | 4.68M | 3.23M | 4.42M | 7.96M | 10.11M | 6.67M | 2.09M | 1.48M | 4.64M | 10.56M | 8.25M | 6.07M | 2.01M | 14.1M | 1.3M |
| Days Payables Outstanding | 75.29 | 106.66 | 98.07 | 124.38 | 160.71 | 204.76 | 214.73 | 242.3 | 214.55 | 177.78 | 154.43 | 81.15 | 170.33 | 91.63 | 127.23 | 92.16 | 97.87 | 128.33 | 300.63 | 705.63 | 1.58K | - | - | - | - | - | -3.49K | -1.22K | -7.35K | -677.86 |
| Short-Term Debt | 55.54M | 46.25M | 19.3M | 20M | 56.16M | 14.7M | 8.52M | 5.02M | 7.86M | 0 | 6.93M | 2.96M | 0 | 3.37M | 4.83M | 2.52M | 1.75M | 0 | 0 | 30K | 84K | 4.89M | 34.5M | 55.85M | 35K | 31K | 32K | 31K | 0 | 100K |
| Deferred Revenue (Current) | 7.49M | 1.27M | 1.4M | 2M | 589K | 673K | 577K | 570K | 498K | 445K | 149K | 554K | 399K | 181K | 77K | 111K | 248K | 345K | 445K | 1.5M | 586K | 11.13M | 13.22M | 614K | 718K | 927K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 50.12M | 25.27M | 11.94M | 11.82M | 17.58M | 18.51M | 16M | 12.7M | 14.96M | 4.34M | 4.12M | 7.94M | 14.98M | 27.68M | 10.83M | 10.01M | 8.46M | 2.74M | 445K | 0 | 586K | 0 | 22.09M | 0 | 0 | 0 | 6.05M | 6.66M | 5.5M | 3.4M |
| Current Ratio | 1.63x | 1.73x | 2.39x | 2.14x | 1.45x | 2.38x | 3.06x | 2.55x | 2.79x | 3.89x | 3.50x | 5.96x | 2.58x | 1.98x | 1.72x | 1.88x | 2.12x | 2.51x | 3.26x | 4.03x | 6.94x | 2.19x | 1.31x | 1.76x | 4.01x | 7.60x | 7.49x | 4.68x | 1.03x | 5.46x |
| Quick Ratio | 1.06x | 1.17x | 1.79x | 1.55x | 1.21x | 2.04x | 2.67x | 2.16x | 2.53x | 3.26x | 3.03x | 5.46x | 2.07x | 1.65x | 1.32x | 1.58x | 1.82x | 1.91x | 2.40x | 3.65x | 6.81x | 2.19x | 1.37x | 1.84x | 4.18x | 7.60x | 7.49x | 4.68x | 1.03x | 5.46x |
| Cash Conversion Cycle | 177.23 | 160.77 | 134.67 | 166.47 | 58.07 | 19.4 | 75.54 | 53.11 | -5.89 | 160.43 | 138.35 | 148.83 | 142.38 | 175.7 | 97.21 | 102.07 | 158.32 | 168.86 | 276.92 | 44.27 | -1.09K | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 47.24M | 56.09M | 80.41M | 76.78M | 32.47M | 73.33M | 57.63M | 58.15M | 26.26M | 36.17M | 18.8M | 22.81M | 11.07M | 1.16M | 4.2M | 5.94M | 4.73M | 130K | 163K | 2K | 32K | 68K | 4.5M | 0 | 16K | 5.05M | 84K | 100K | 5M | 0 |
| Long-Term Debt | 9.38M | 40.55M | 64.86M | 59.8M | 13.64M | 54.72M | 39.59M | 39.41M | 22.01M | 29.8M | 12.44M | 16.85M | 9.87M | 0 | 2.9M | 4.7M | 3.13M | 0 | 0 | 0 | 0 | 0 | 4.5M | 0 | 0 | 51K | 84K | 115K | 0 | 0 |
| Capital Lease Obligations | 32.23M | 10.15M | 11.66M | 13.75M | 15.33M | 16.26M | 16.87M | 18.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6K | 15K | 0 | 2K | 32K | 68K | 0 | 0 | 16K | 51K | 84K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -100K | 150K | 122K | 115K | 89K | 62K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 37.86M | 5.39M | 3.89M | 3.24M | 3.5M | 2.34M | 1.17M | 327K | 4.25M | 6.38M | 6.21M | 5.8M | 1.08M | 1.07M | 1.24M | 1.24M | 1.59M | 115K | 163K | 0 | 0 | 0 | 0 | 0 | 0 | 4.95M | -84K | -15K | 0 | 0 |
| Total Liabilities | 154.62M | 156.89M | 144.02M | 144.3M | 149.53M | 151.88M | 117.61M | 108.48M | 78.94M | 59.3M | 45.69M | 44.7M | 40.06M | 40.59M | 29.81M | 27.05M | 24.43M | 13.04M | 13.06M | 18.32M | 14.85M | 23.39M | 80.59M | 65.94M | 16.78M | 21.5M | 12.24M | 8.8M | 19.6M | 4.8M |
| Total Debt | 64.92M | 96.95M | 98.1M | 96M | 87.24M | 87.59M | 66.89M | 64.45M | 29.87M | 29.8M | 19.38M | 19.87M | 9.87M | 3.37M | 7.72M | 7.22M | 4.89M | 24K | 0 | 32K | 116K | 4.96M | 39M | 55.85M | 51K | 82K | 116K | 100K | 5M | 100K |
| Net Debt | 37.07M | 76.98M | 77.83M | 84.35M | 51.65M | 38.83M | 30.3M | 29.46M | 1.01M | 16.11M | -3.19M | -51.15M | -12.91M | -26.12M | -18.97M | -18.28M | -24.05M | -17.26M | -10.3M | -19.59M | -46.17M | -819K | -169K | 32.69M | -22.38M | -64.42M | -71.76M | -3.4M | -1.2M | -11.5M |
| Debt / Equity | 0.95x | 1.49x | 1.72x | 1.80x | 1.27x | 1.02x | 0.64x | 1.13x | 0.35x | 0.77x | 0.34x | 0.21x | 0.24x | 0.08x | 0.40x | 0.39x | 0.21x | 0.00x | - | 0.00x | 0.00x | 0.14x | 1.81x | 1.06x | 0.00x | 0.00x | 0.00x | 0.00x | 3.85x | 0.00x |
| Debt / EBITDA | -4.09x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -2.34x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.63x | -4.36x | -1.34x | -3.45x | -6.26x | -9.98x | -14.90x | -11.05x | -13.31x | -17.76x | -24.66x | -33.92x | -63.37x | -82.28x | -27.45x | -16.47x | -23.41x | -79.88x | -2917.10x | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 68.29M | 64.97M | 56.9M | 53.44M | 68.56M | 85.62M | 103.81M | 57.05M | 84.52M | 38.94M | 57.79M | 94.77M | 41.71M | 42.8M | 19.11M | 18.31M | 23.73M | 21.45M | 34.28M | 59.89M | 100.97M | 35.27M | 21.49M | 52.53M | 56.17M | 106.75M | 81.92M | 33M | 1.3M | 22.5M |
| Equity Growth % | 61.86% | 14.18% | 6.46% | -22.05% | -19.92% | -17.52% | 81.95% | -32.5% | 117.05% | -32.61% | -39.02% | 127.2% | -2.54% | 123.98% | 4.34% | -22.83% | 10.65% | -37.43% | -42.76% | -40.69% | 186.24% | 64.15% | -59.09% | -6.48% | -47.39% | 30.31% | 148.25% | 2438.46% | -94.22% | - |
| Book Value per Share | 0.35 | 0.34 | 0.31 | 0.30 | 0.39 | 0.50 | 0.63 | 0.41 | 0.64 | 0.36 | 0.57 | 0.98 | 0.54 | 0.63 | 0.35 | 0.38 | 0.59 | 0.62 | 1.06 | 1.88 | 3.53 | 1.47 | 0.97 | 2.71 | 3.55 | 7.07 | 6.26 | 2.97 | 0.14 | 2.69 |
| Total Shareholders' Equity | 68.29M | 64.22M | 56.15M | 52.65M | 67.61M | 84.62M | 103.81M | 57.05M | 84.52M | 38.94M | 57.79M | 94.77M | 41.71M | 42.8M | 19.11M | 18.31M | 23.73M | 21.45M | 34.28M | 59.89M | 100.97M | 35.27M | 21.49M | 52.53M | 56.17M | 106.75M | 81.92M | 33M | 1.3M | 22.5M |
| Common Stock | 200K | 192K | 186K | 181K | 177K | 174K | 168K | 144K | 136K | 115K | 103K | 99K | 80K | 72K | 56K | 51K | 47K | 39K | 33K | 32K | 32K | 23K | 22K | 22K | 16K | 16K | 14K | 0 | 0 | 0 |
| Retained Earnings | -1.08B | -1.08B | -1.07B | -1.04B | -1.01B | -964.34M | -909.97M | -850.11M | -778.87M | -721.3M | -660.72M | -597.81M | -541.94M | -503.19M | -459.85M | -443.94M | -426.95M | -410.04M | -385.91M | -356.73M | -311.42M | -306.64M | -319.71M | -288.55M | -230.29M | -173.09M | -123.73M | -87.5M | -64.4M | -34.9M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -323K | -156K | -400K | -1.27M | -2.79M | -149K | 674K | 114K | -281K | -97K | 103K | 7.29M | -31K | 7K | -8.32M | 0 | 108K | 58K | 212K | 75K | -22K | -295K | -324K | -10.32M | -7.1M | -4.6M | -3.53M | -2.9M | -2.3M | -1.7M |
| Minority Interest | 733K | 741K | 751K | 794K | 952K | 998K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and dilution risk
As reported in recent financial statements, Cerus's equity base has remained under pressure, with retained earnings stagnating at negative $1.1 billion, signaling that the company's ongoing expansion efforts are failing to generate the internal capital necessary to offset persistent operational losses and sustain its long-term growth trajectory.
The persistent negative retained earnings suggest that the company is effectively consuming its equity to fund R&D and commercialization efforts. Investors should monitor whether the recent revenue growth can eventually translate into a stabilization of the equity base or if further capital raises will be required.
Based on reported figures, Cerus's debt-to-equity ratio has fluctuated significantly, reaching 0.95 in 2026Q1, which indicates that the company relies heavily on debt financing to bridge the gap between its current cash burn and the long-term potential of its pathogen reduction technology pipeline.
The reliance on debt in a pre-profitability state creates a precarious financial position, particularly as the company approaches maturity on its obligations. This leverage appears to be a necessity-driven strategy rather than a strategic choice, which may limit management's flexibility in future capital allocation decisions.
According to recent SEC filings, Cerus's cash position of $27.9 million as of 2026Q1, while improved from the previous quarter, remains dangerously thin relative to its ongoing operating expenses, suggesting that the company lacks a sufficient buffer to withstand unexpected shocks or delays in its clinical trial milestones.
The current ratio of 1.63 indicates that while short-term assets cover current liabilities, the quality of these assets—largely tied to inventory and receivables—may be less liquid than the headline number suggests. This liquidity profile warrants further investigation into the company's ability to fund operations without dilutive financing.
Data from the balance sheet reveals that the company's asset base is heavily weighted toward non-cash items, with net PPE of $18.7 million, which may be subject to impairment if the commercial adoption of the INTERCEPT system fails to meet the aggressive growth targets currently priced in.
The reliance on specialized hardware and inventory creates a risk of obsolescence, particularly if regulatory requirements or clinical standards shift. Investors should be wary that the book value of these assets may not reflect their true realizable value in a distressed scenario, potentially overstating the company's tangible net worth.
Quick answers to the most common questions about buying CERS stock.
As of 2025, Cerus Corporation (CERS) had total assets of $221.9M including $174.4M in current assets.
Cerus Corporation (CERS) carries total debt of $96.9M, offset by $82.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Cerus Corporation (CERS) has total shareholders' equity (book value) of $64.2M ($0.34 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Cerus Corporation (CERS) reported a current ratio of 1.73x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.